Here, the increased plasma ET-1 level is discussed as a major factor in the pathogenesis of the described signs and symptoms associated with FS as: reduced thirst sensation [42], atypical headaches and migraines [43, 44] and increased pain sensation [45]. This evidence concerns the gene EDN1 and migraine disorder.